Lindbrook Capital, LLC - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 195 filers reported holding BEAM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$13,824
-42.2%
590
-18.5%
0.00%
-50.0%
Q1 2024$23,921
+30.8%
724
+7.7%
0.00%0.0%
Q4 2023$18,292
+117.9%
672
+92.6%
0.00%
+100.0%
Q3 2023$8,393
+672.8%
349
+926.5%
0.00%
Q2 2023$1,086
+343.3%
34
+325.0%
0.00%
Q1 2023$245
-90.6%
8
-88.1%
0.00%
Q4 2022$2,620
-12.7%
67
+11.7%
0.00%
-100.0%
Q3 2022$3,000
+200.0%
60
+172.7%
0.00%
Q2 2022$1,0000.0%22
+83.3%
0.00%
Q1 2022$1,000120.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$74,937,60345.33%
HSG Holding Ltd 796,089$25,419,1222.91%
Deep Track Capital, LP 1,317,316$42,061,9001.95%
Redmile Group, LLC 1,485,199$47,422,4041.82%
ARK Investment Management 8,382,595$267,656,2461.77%
Casdin Capital, LLC 570,000$18,200,1001.59%
Yiheng Capital Management, L.P. 463,800$14,809,1340.80%
Temasek Holdings (Private) Ltd 4,317,789$137,867,0030.80%
Alphabet Inc. 321,604$10,268,8150.55%
FARALLON CAPITAL MANAGEMENT LLC 3,441,522$109,887,7970.55%
View complete list of BEAM THERAPEUTICS INC shareholders